Management of Suspected Gout Flare in a 65-Year-Old Man
For a 65-year-old man with left ankle pain suspected to be a gout flare, oral colchicine, NSAIDs, or glucocorticoids should be used as first-line therapy, with the specific choice based on the patient's comorbidities and medication history. 1
Diagnostic Approach
When evaluating suspected gout in this patient, consider:
- Clinical presentation: Acute onset of severe pain, erythema, and swelling in the ankle joint
- Risk factors: Age, gender, previous episodes, diet high in purines, alcohol consumption
- Joint aspiration: If diagnosis is uncertain, joint aspiration with polarized microscopy to identify monosodium urate crystals is the gold standard for diagnosis
First-Line Treatment Options
The 2020 American College of Rheumatology guidelines strongly recommend three equally effective first-line options for acute gout flare management:
Colchicine:
NSAIDs (e.g., naproxen 500mg twice daily for 5 days)
- Avoid in patients with renal impairment, peptic ulcer disease, or uncontrolled hypertension
Glucocorticoids:
- Oral: Prednisone 30-35mg daily for 3-5 days
- Intra-articular: Option for single joint involvement
- Parenteral (IM/IV): Preferred when oral dosing not possible 1
Treatment Selection Considerations
Choose therapy based on:
- Comorbidities (renal function, cardiovascular disease, diabetes)
- Medication interactions
- Previous response to therapy
- Timing since symptom onset
Special Considerations for Elderly Patients
For this 65-year-old patient:
- Use caution with NSAIDs due to increased risk of GI bleeding and renal impairment
- Consider lower starting doses of colchicine if renal function is impaired 3
- Glucocorticoids may be preferred if NSAIDs are contraindicated, but monitor for effects on blood glucose if diabetic 2
Adjunctive Measures
- Topical ice application is conditionally recommended as an adjuvant treatment 1
- Rest and elevation of the affected joint
- Adequate hydration
Follow-up and Long-term Management
If this is a recurrent episode (≥2 attacks per year) or if tophi are present, consider:
Urate-lowering therapy (ULT):
- Allopurinol is the strongly recommended first-line agent 1
- Start at low dose (100 mg daily or lower in renal impairment) with gradual titration
- Target serum urate level <6 mg/dL
Prophylaxis when starting ULT:
- Strongly recommended to prevent flares during ULT initiation
- Continue for 3-6 months after reaching target urate level 1
- Options include low-dose colchicine, NSAIDs, or low-dose prednisone
Lifestyle modifications:
Common Pitfalls to Avoid
- Delaying treatment beyond 24 hours of symptom onset
- Using high-dose colchicine regimens
- Discontinuing ULT during acute flares
- Failing to provide prophylaxis when initiating ULT
- Inadequate dose titration of allopurinol to reach target serum urate levels 2
- Overlooking drug interactions, particularly with colchicine and P-glycoprotein/CYP3A4 inhibitors 3
By following these evidence-based recommendations, the patient's acute gout flare can be effectively managed while minimizing the risk of future attacks.